Statins and selective inhibition of Rho kinase protect small conductance calcium-activated potassium channel function (K(Ca)2.3) in cerebral arteries.
<h4>Background</h4>In rat middle cerebral and mesenteric arteries the K(Ca)2.3 component of endothelium-dependent hyperpolarization (EDH) is lost following stimulation of thromboxane (TP) receptors, an effect that may contribute to the endothelial dysfunction associated with cardiovascul...
Saved in:
| Main Authors: | Alister J McNeish, Francesc Jimenez-Altayo, Graeme S Cottrell, Christopher J Garland |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0046735&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rho Kinase in Eye Disease
by: Naoki Okumura, et al.
Published: (2017-01-01) -
Effect of alpha-linolenic acid on aminoglycoside nephrotoxicity and RhoA/Rho-kinase pathway in kidney
by: Percin Pazarci, et al.
Published: (2024-10-01) -
Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor
by: Jiannong Dai, et al.
Published: (2024-12-01) -
Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases
by: Naoki Okumura, et al.
Published: (2017-01-01) -
Latest Update in Glaucoma: The first approvals for Rho Kinase inhibitors
by: Jatinder Bali, et al.
Published: (2020-04-01)